Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5

Estrogen and progesterone receptors are possible markers for suggesting a mammary origin of metastatic carcinoma, but are useless in cases of triple negative breast cancers (TNBC). Five other potential markers of breast origin were investigated on tissue microarrays in a series of TNBCs showing kera...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Zombori Tamás
Cserni Gábor
Dokumentumtípus: Cikk
Megjelent: 2018
Sorozat:PATHOLOGY AND ONCOLOGY RESEARCH 24 No. 2
doi:10.1007/s12253-017-0246-y

mtmt:3222112
Online Access:http://publicatio.bibl.u-szeged.hu/16822
LEADER 02376nab a2200217 i 4500
001 publ16822
005 20190924094146.0
008 190924s2018 hu o 0|| zxx d
022 |a 1219-4956 
024 7 |a 10.1007/s12253-017-0246-y  |2 doi 
024 7 |a 3222112  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Zombori Tamás 
245 1 0 |a Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5  |h [elektronikus dokumentum] /  |c  Zombori Tamás 
260 |c 2018 
300 |a 259-267 
490 0 |a PATHOLOGY AND ONCOLOGY RESEARCH  |v 24 No. 2 
520 3 |a Estrogen and progesterone receptors are possible markers for suggesting a mammary origin of metastatic carcinoma, but are useless in cases of triple negative breast cancers (TNBC). Five other potential markers of breast origin were investigated on tissue microarrays in a series of TNBCs showing keratin 5 expression, consistent with a basal-like phenotype. GATA-3 staining was observed in 82 of 115 triple negative cases (71.3%) including 23 cases with >5% staining. Mammaglobin staining was detected in 30 cases (26.0%) including 12 with >5% staining. GCDFP-15 was seen in 23 cases (20.0%) including 9 with >5% staining. NY-BR-1 positivity was present in 7 cases (6.0%) including 3 patients with >5% staining. BCA-225 staining was observed in 74 cases (64.3%); however this latter marker lacks also specificity owing to the reported widespread staining in other malignancies. GATA-3, mammaglobin and GCDFP-15 coexpression was seen in one case (0.9%), whereas GATA-3 and mammaglobin or mammaglobin and GCDFP-15 coexpression was present in 2 and 2 cases (1.7%), respectively. Using at least 5% staining as cut-off, the expression of any of the last 4 markers was 34.7%. The expression of GATA-3, mammaglobin, GCDFP-15 and NY-BR-1 is lower in TNBC-s than in breast carcinomas in general, and this may be even lower in basal-like carcinomas. Although these markers are not fully specific, by using them, a subset of basal-like TNBC-s can be identified as of mammary origin. However, a substantial proportion will not show any staining with any of these markers. 
700 0 1 |a Cserni Gábor  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16822/1/POR2018-9-259-267POSTPRINT.pdf  |z Dokumentum-elérés